Lung Cancer

NSCLC of Upper Lobe of Right Lung

Male, 68 years

Patient Internal ID: 275816445

ICD-10 code

C45.0 Mesothelioma of Pleura

Diagnosis (Incl. Metastases/Stage) and Year

January 2020
Non-Small Cell Lung Carcinoma of the Upper Lobe of the Right Lung cT4N3M1 Stage IVb EGFR+. Metastases in the Left Lung, Abdominal Lymph Nodes, Liver, Adrenal Glands, Brain and Bones.

Previous Treatment

Target Therapy (Afatinib), Radiation Therapy, Gama Knife, Chemotherapy (Cisplatin and Pemetrexed), Chemotherapy (Docetaxel and Nintedanib).

Prognosis and Survival Expectation

The prognosis remains poor, with a median survival of 16 months and the 5-year relative survival rate is about 9%.

Treatment Provided

Autologous DCV (6 doses) and CIK (4 doses) over a period of 4 months.

Patient Survival/Condition and Year
Date of Review: 15/10/2023

The patient has survived for 22 months. It can be concluded that the addition of Immunotherapy, alongside Target therapy, Radiation Therapy and Chemotherapy, has extended patient survival by an estimate of 8 months.

Disclaimer

We encourage you to learn more about your condition and treatment options to make informed decisions about your healthcare. However, please keep in mind that not all information available online or in other sources is accurate or relevant to your specific situation. It’s important to rely on credible, evidence-based sources such as official medical websites, peer-reviewed publications, or information provided by professional healthcare organizations. Always discuss any information you find with your healthcare provider before making decisions, as they can help clarify details, address concerns, and ensure the information is appropriate for your unique needs.

Ok